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ABSTRACT
Background: Hypertension is one of the main causes of cardiovascular disease. Patients with 
hypertension have increase risk of heart failure compared to populations with normal blood 
pressure. Clinical evidence shows diastolic dysfunction (DD) can lead to heart failure. Diagnostic 
of DD with echocardiography is important but access to echocardiography machines is limited 
compared to electrocardiography (ECG). ECG research correlates P-wave dispersion (PWD) 
with DD. The aim of this study is to determine the value of PWD to diagnose DD in patients 
with hypertension.
Methods: A cross sectional study was conducted in patients with hypertension at Dr. Sardjito 
Hospital. Patients received echocardiography, ECG, blood pressure measurement and data 
recording. The diastolic dysfunction was determined based on 2016 ASE/EACVI criteria. We 
conducted ROC analysis to determine the cut-off point of P-wave dispersion and the area under 
the curve (AUC) value, and bivariate analysis on demographic and clinical factors related to 
PWD. Multivariate analysis was performed to determine the independent factors affecting PWD.
Results: 113 patients met the criteria of the study subjects, with 47 men (37.2%), mean age 
58.32±11.17 years. Thirteen (11.5%) subjects had DD and 37 subjects (32.7%) with increased 
PWD. Results showed increased PWD above 71.4 m.s with AUC 76.2%, sensitivity 75%, 
specificity 72.2%, positive predictive value 33.3%, negative predictive value 96%, and accuracy 
of 72.5% in diagnosing DD.
Conclusion: This is the first study to examine the diagnostic value of PWD to detect diastolic 
function based on 2016 ASE/EACVI criteria. We found PWD above cut-off point 71.4 m.s has 
a moderate diagnostic value for detecting DD in patients with hypertension.
Keywords: Hypertension, diastolic dysfunction, P-wave dispersion.
INTISARI
Latar Belakang: Hipertensi merupakan salah satu penyebab utama penyakit kardiovaskular. 
Risiko gagal jantung pada pasien hipertensi meningkat dibandingkan populasi normal. 
Disfungsi diastolik dapat menimbulkan gejala gagal jantung. Penegakan diagnosis disfungsi 
diastolik dengan ekokardiografi sangat penting namun akses pelayanan ekokardiografi terbatas 
dibandingkan akses terhadap EKG.  Dispersi gelombang P diketahui berhubungan dengan 
disfungsi diastolik.  Penelitian ini bertujuan untuk mengetahui nilai diagnostic dispersi gelombang 
P terhadap disfungsi siastolik pada pasien hipertensi.
Metode Penelitian: Studi potong lintang ini dilakukan terhadap pasien dengan hipertensi yang 
dilakukan periksaan ekokardiografi di RSUP Dr. Sardjito. Setelah dilakukan ekokardiografi pasien 
kemudian dilakukan perekaman EKG dan pengukuran tekanan darah serta pencatatan data. 
Disfungsi diastolik ditentukan dengan kriteria ASE/EACVI tahun  2016. Analisis ROC dilakukan 
untuk menentukan cut-off point pemanjangan dispersi gelombang P dan melihat nilai AUC. 
Analisis bivariat dilakukan terhadap faktor demografi dan klinis yang berhubungan dengan 
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INTRODUCTION
Hypertension is one of the leading cause of 
cardiovascular disease. Study in Malaysia showed 
that the prevalence of hypertension reached 24% 
and is a major cause of heart failure with high 
mortality.1Hypertension causes thickening of the 
ventricular wall as compensation for increased 
pressure on the ventricular wall which ultimately 
results in concentric hypertrophy of the left 
ventricle and causes diastolic dysfunction.2 In 
the left ventricular diastolic dysfunction condition, 
there will be an increase in end diastolic pressure 
and increase of the dimension of the left atrium. 
The increased left atrial pressure and dimension 
increase the risk of atrial fibrillation, which in turn 
will increase diastolic dysfunction severity and 
worsening of symptoms of heart failure3.
Diagnosing diastolic dysfunction with 
echocardiography is important because of the 
large number of morbidities that can result 
from poorly handled diastolic dysfunction, but 
access to echocardiography machines is limited. 
Electrocardiography machines are commonly 
found in health care providers. We examined 
ECG parameters, which could provide diagnostic 
indicators to diastolic dysfunction (DD).The 
ECG examination correlates P-wave dispersion 
(PWD) with DD. In this study, PWD was obtained 
by substracting the shortest duration of the 
P-wave from the longest P-wave duration in 
various ECG leads.One recent study found that 
P-wave parameters correspond to left atrial 
volume index (LAVI) and left ventricular diastolic 
dysfunction.4
We conducted this study in  order to 
examine the diagnostic value of P-wave 
dispersion in predicting the occurence of DD in 
patients with hypertension.
METHOD
An analytic observational study using cross 
sectional design was conducted in RSUP Dr. 
Sardjito Hospital, Yogyakarta, Indonesia from 
March to April 2017. Echocardiography and ECG 
data were examined on the same day starting 
from the issuance of ethical clearance until the 
research sample was fulfilled. Target populations 
were patients with hypertension who underwent 
echocardiography as an outpatient. Inclusion 
criteria included: male or female aged 18-75 years 
old with diagnosis of hypertension with normal 
cardiac systolic function, and normokinetics 
determined by echocardiography, and willing 
to complete this research. Exclusion criteria 
included: patients with congenital heart disease, 
primary valve disease, permanent pacemakers, 
P-wave dispersion cannot be calculated due to 
unidentifiedP-wave, atrial fibrillation, artifacts, 
and/or indeterminate diastolic function based on 
ASE/EACVI 2016 recomendation.The required 
sample size was determined to be 81 subjects.
Demographic and clinical data include: 
age, sex, pulse rate, systolic and diastolic 
blood pressure, diabetes mellitus, smoking 
dispersi gelombang P, dilanjutkan analisis multivariat untuk mengetahui faktor independen 
yang mempengaruhi dispersi gelombang P.
Hasil: Terdapat 113 pasien yang memenuhi kriteria subyek penelitian, 47 (37,2%) laki-laki 
dengan rerata usia 58,32±11,17 tahun,13 (11,5%) subyek memiliki disfungsi diastolik dan 
37 subyek (32,7%) dengan pemanjangan dispersi gelombang P. Penelitian ini mendapatkan 
pemanjangan dispersi gelombang P di atas cut-off point 71,4 mili detik memiliki nilai AUC 
76,2% sensitivitas 75%, spesifisitas 72,2%, nilai duga positif 33,3%, nilai duga negatif 96%, 
dan akurasi 72,5% dalam mendiagnosis disfungsi diastolik.
Simpulan: Studi ini adalah yang pertama meneliti nilai diagnostik dispersi gelombang P terhadap 
fungsi diastolik berdasarkan kriteria ASE/EACVI 2016. Kami menemukan pemanjangan dispersi 
gelombang P diatas 71,4 mili detik memiliki nilai diagnostik sedang untuk mendeteksi disfungsi 
diastolik pada pasien hipertensi.
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history, ischemic heart disease, use of ACE 
inhibitors, angiotensin II receptor blockers 
(ARB), calcium channel blockers, beta blockers, 
thiazide diuretics, and echocardiographic criteria 
recorded in the Case Report Form.
ECG examination
A 12 lead EGG recording was done in 
patients with supine position, paper speed of 
50 mm/sec and amplitude of 20 mm/mV using 
General Electric (GE) Mac i ECG machine. 
The ECG recording was then embedded in a 
sequence on paper and then scanned using a 
HP Deskjet 2520HC scanner with a resolution 
of 300 dot per inch (DPI) and stored in Joint 
Photographic Experts Group (JPG) format and 
then analysed using the ImageJ software on a 
high resolution computer screen. The value of 
P-wave dispersion is obtained by substracting the 
longest duration of the P-wave and the shortest 
P-wave recorded in twelve leads in a single ECG 
recording. The P-wave measurement starts from 
the beginning of the positive deflection until back 
to the isoelectric line.5
Echocardiography examination
Echocardiographic examination was 
performed using the echocardiography machine 
GE Vivid 7 Pro (GE Vingmed Ultrasound 
AS, Horten, Norway) and GE Vivid S6 N (GE 
Vingmed Ultrasound AS, Horten, Norway) in 
echocardiography division in Dr. Sardjito General 
Hospital Yogyakarta. The diastolic dysfunction 
diagnosis used in this study is based on the 
American Society of Echocardiography 2016 
recommendations.6
Statistical analysis
Statistical analysis was performed with IBM® 
SPSS® version 22 for Windows. The numerical 
variables are presented in the form of the mean±SD 
(standard deviation) and categorical variables 
will be presented as a percentage. Categorical 
variables testing are compared with 2x2 tables 
using Chi Squared (x2) or Fisher Exact Tests. The 
cut-off point of P-wave dispersion was determined 
using the sensitivity-specificity graph from the 
receiver operator characteristics (ROC) curve. 
Numerical data are compared by using unpaired 
Student t-test or Mann Whitney U test based on 
the normality of data distribution. Confounding 
variables were analyzed using bivariate analysis 
followed by multivariate analysis. If there was a 
variable with a value of p <0.25 in the bivariate 
test, it was included in the multivariate analysis. 
The p value <0.05 was considered statistically 
significant. The assessment of the consistency of 
ECG readings and the measurement of diastolic 
function by echocardiography was performed with 
Kappa, if the coefficient of Kappa > 0.8 with p <0.05 
measurement was considered similar. Sensitivity, 
specificity, positive and negative predictive values 
were assessed using 2x2 tables. 
Ethical Consideration
This study was ethicaly approved by the 
ethical committee of medical research Faculty of 
Medicine,Universitas Gadjah Mada, Yogyakarta 
and permission from the Dr. Sardjito General 
Hospital Yogyakarta, Indonesia.
RESULTS
This research was conducted from March 
to April 2017 in Dr. Sardjito Hospital. There were 
270 subjects with a history of hypertension. The 
total subjects met the inclusion criteria were 113 
subjects.
The subjects consisted of 42 men (37%) 
and 71 women (63%). The mean age of the 
subjects was 58.29 ± 11.21 years with median 
systolic blood pressure 140 mmHg, while diastolic 
blood pressure with median 80 mmHg. Seven 
subjects (6.1%) had ECG recording indicating 
ischemic heart disease and 13 subjects (11.5%) 
had diabetes. Fifty-three subjects (47%) received 
one or more antihypertensive medications, with 
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most subjects using calcium group blockers 29 
subjects (25.6%), followed by ARB 27 subjects 
(23.9%) and ACE inhibitor 11 subjects (9.7%).
The ROC curve analysis showed AUC 
value 76.2% (p=0.003; 95% CI 0.620% - 0.920%) 
at P-wave dispersion cut-off point ≥ 71.4 ms with 
sensitivity 75% and spesificity 72.3%. Area under 
the curve (AUC) are in the area 70-80% so that 
the strength of diagnostic test in this study is 
moderate.7 When we continued to analyze the 
P-wave dispersion with cut-off point 71.4 ms using 
2x2 table then we found sensitivity 75%, specificity 
72.2%, positive predictive value 33.3%, negative 
predictive value 96%, and accuracy of 72%.
Several confounding variables which 
have been known to affect P-wave dispersion 
and diastolic dysfunction include: age, gender, 
diabetes, smoking, ischemic heart disease, use 
of beta-blocker drugs, calcium channel blockers, 
AR blockers, ACE inhibitors, and thiazide 
diuretics. Therefore, it was necessary to use 
Table1.Baseline characteristics of the study 
subjects
Variables Frequency
Male sex, n(%) 42 (37.2%)
Age ± SD (years old)* 58.32 ±11.17
Blood pressure (mmHg)
   Systolic** 140 (100-200)
   Diastolic** 80 (50-110)
Pulse (bpm)** 77 (47-100)
Diabetes Melitus, n(%) 13 (11.5%)
Ischemic Heart Disease, n(%) 7 (6.2%)
Active smoker, n(%) 15 (13.3%)
ACE inhibitor, n (%) 11 (9.7%)
AR blocker, n(%) 27 (23.9%)
Beta blocker, n(%) 17 (15%)
CCB, n(%) 29 (25.6%)
Note: ACE= Angiotensin Converting Enzyme, 
AR=Angiotensin II Receptor ,CCB= Calcium Channel 
Blocker
*normal data distribution, presented in mean± s.d, 
analysed using independent sample t-test
**abnormal data distribution, presented in median 
(minimum-maximum value) analysed using Mann-
Whitney Test
Figure1. Receiver Operating Curve (ROC) of 
diagnostic values of P-wave dispersion to detect 
diastolic function in patients with hypertension
bivariate testing to find the correlation of these 
factors to P-wave dispersion. Factors that have 
p> 0.25 on the bivariate test were analysed using 
multivariate test to determine if these factors 
independently correlated with P-wave dispersion 
and the result was considered significant if it has 
p<0.05.
Bivariate analysis was performed on each 
confounding factor of P-wave dispersion (Table 
2). There were significant differences between 
groups of subjects with ischemic heart disease 
and those who received therapy of ARB (p <0.05), 
while subjects with diastolic blood pressure ≥ 90 
mmHg, who had a history of smoking, and had 
beta-blocker therapy reached a value of p <0.25, 
so further analysis was required with multivariate 
analysis.
Based on the results of the multivariate 
analysis, it can be concluded that the use of ARB 
is an independent variable that affects the P-wave 
dispersion in this study with p value <0.05.
DISCUSSION
Our study involved 113 subjects with 
the majority of subjects being female (62.8%) 
with an average age of 58.32 ± 11.17 years. 
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Figure 2. Sensitivity-specificity graph to define optimal cut-off point of P-wave dispersion to detect 
diastolic function in patients with hypertension
Table 2. Bivariate analysis of clinical characteristic and P-wave dispersion
Variable
P-wave dispersion
OR 95% CI p
≥71.4ms (n=37) <71.4ms (n=76)
Sex
Male 15 (40%) 27 (36%) 1.237 0.552-2.773 0.605
Age (years old)
   ≥ 58 19 (51%) 41 (54%) 0.901 0.410-1.979 0.795
Systolic BP (mmHg)
   ≥140 27 (73%) 55 (72%) 1.031 0.426-2.492 0.946
Diastolic BP (mmHg)
   ≥ 90 15 (40%) 21 (28%) 1.786 0.781-4.082 0.167*
Pulse (bpm)
   ≥76 20 (55%) 37 (49%) 1.24 0.564-2.726 0.592
Diabetes Melitus 6 (16%) 7 (9%) 1.908 0.592-6.146 0.273
Active smoker 29 (78%) 69 (91%) 2.719 0.902-8.195 0.068*
Ischemic Heart Disease 5 (12%) 2 (3%) 5.781 1.065-31.377 0.037**
ACE inhibitor 4 (11%) 7 (9%) 1.195 0.327-4.369 0.748
AR blocker 15 (40%) 12 (16%) 3.636 1.478-8.948 0.004**
Beta blocker 8 (22%) 9 (9%) 2.054 0.721-5.853 0.172*
CCB 9 (24%) 20 (26%) 0.9 0.363-2.232 0.82
Note: ACE= Angiotensin Converting Enzyme, AR =Angiotensin II Receptor, CCB=Calcium Channel Blocker, 
BP=Blood preesure, *p<0.25, **p<0.05.
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P-wave dispersion data in this study has normal 
distribution with mean value 63.94±19.51 ms, 
then from calculation with ROC curve, we 
found the cut-off point of P-wave dispersion 
71.4 m.s. The diagnostic values  obtained using 
the cut-off point were 75% sensitivity, 72.2% 
specificity, 33.3% positive predictive value, and 
a negative predictive value of 96%. This result 
is different compared to the diagnostic value of 
P-wave dispersion based on a study by Taha et 
al. (2015) which obtained a 98% sensitivity and 
64% specificity with a 45 m.s cut off point based 
on the ROC curve.8
The differences of these results may 
be due to differences in characteristics of the 
study subjects, diagnostic criteria for diastolic 
dysfunction, and ECG reading methods. Subjects 
in our study were all patients with hypertensive 
and there was a significant difference in the 
proportion of subjects with diastolic dysfunction 
compared to the total number of study subjects. 
In the study by Taha et al. (2015) the study 
subjects were the patients who were planned 
to do the stress ECG test with the inclusion 
criteria of patients with negative stress test,and a 
history of hypertension was only found in 38.5% 
of all subjects. The diastolic dysfunction criteria 
in this study was to use the ratio parameter 
E/e’ where the value of ≥ 15 was classified as 
diastolic dysfunction, with 60% of subjects having 




≥71.4 m s (n=37) <71.4 m s (n=76)
LVIDd (mm)* 46.35 ±5.79 44.46 ±4.28 0.054
LVPWDd (mm)** 10 (6-16) 9 (6-14) 0.228
IVSDd (mm)** 11 (7-16) 10 (6-17) 0.133
LAVI** 22 (10-60) 21 (11-44) 0.534
e’ septal velocity(cm/s)** 7 (3-13) 9 (5-17) 0.001
e’ lateral velocity (cm/s)** 9 (4-15) 11 (6-29) 0.001
E/e’ ratio** 7.57 (0-26.73) 7.22 (0.9-17) 0.028
TR maximum velocity(m/s)** 0 (0-144) 0 (0-29) 0.5
deceleration Time (dT)** 198 (0-466) 198 (98-434) 0.497
LV Mass** 162.1(78.3-358.9) 138.7 (59.91-334.24) 0.065
Note: LVIDd=Left ventricular internal diameter end diastole, LVPWd=Left ventricular posterior wall end 
diastole,IVSd=Interventricular septal end diastole,LAVI=Left Atrial Volume Index, LV=Left Ventricle, TR= Tricuspid 
Regurgitation.
*normal data distribution, presented in mean± s.d ,analysed using independent sample t-test
**abnormal data distribution, presented in median (minimum-maximum value) analysed using Mann-Whitney Test
Table 4. Multivariate analysis of factors which affect P-wave dispersion
Variable
P-wave disperion
OR  95%CI P
≥71.4ms (n=37) <71.4ms (n=76)
Diastolic BP 15 (40%) 21 (28%) 0.406 0.163-1.009 0.052
Ischemic Heart Disease 5 (12%) 2 (3%) 0.226 0.037-1.366 0.105
Active smoker 29 (78%) 69 (91%) 2.454 0.733-8.219 0.145
AR blocker 15 (40%) 12 (16%) 0.250 0.094-0.664 0.005*
Beta blockers 8 (22%) 9 (9%) 0.703 0.214-2.310 0.562
Note: AR=Angiotensin II Receptor ,  BP=Blood preesure, *p<0.05
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diastolic dysfunction. The ECG was read using 
a magnifying glass to obtain P-wave dispersion 
with characteristics: mean 47 ± 10 ms in subjects 
with normal diastolic function and 69 ± 10 ms 
in subjects with diastolic dysfunction. A study 
from Dilaveris et al. (1999) comparing various 
P-wave measurement methods to obtain P-wave 
duration, found that measurements are more 
stable and reliable by using high resolution digital 
screens compared to reading using ECG paper 
using magnifying glass and calipers.9
The AUC value of this research is 76.2% 
in the range of  70 - 80% so that the strength 
of the diagnostic test in this study is moderate. 
Another approach is clinical, which is compared 
to the AUC value of the existing diagnostic 
methods. The study of Tsai et al. (2013) about 
the correlation of P-wave dispersion with LAVI 
and diastolic dysfunction shows an increase in 
P-wave dispersion above 65 m.s has a 61.7% 
AUC with a sensitivity of 61.8% and a specificity 
of 56.95 in detecting diastolic dysfunction.4 
Another study by Srivastava et al. (2005) on 
the role of echocardiographic doppler in the 
assessment of diastolic dysfunction showed the 
AUC values  for each of the E ‘lateral, E’ medial, 
E / e ‘velocity parameters were 77%, 80%, and 
79%.10
Gunduz et al. (2005) studied the relationship 
of P-wave dispersion with diastolic dysfunction 
and compared with the normal population, with 
54% of subjects suffering from hypertension 
with diastolic dysfunction were divided into 
3 classes in this study, and it was found that 
P-wave dispersion increased significantly 
in patients with diastolic dysfunction (53 ± 9 
m.s vs. 43 ± 9; p <0.01), but the difference 
of P-wave dispersion between the 3 classes 
of diastolic dysfunction was not significantly 
different (p> 0.05).11 Another study compared 
P-wave dispersion in hypertensive patients 
with and without a paroxysmal AF history 
found that P-wave dispersion > 44 m.s can 
distinguish hypertensive patients with and without 
paroxysmal atrial fibrillation with 77% sensitivity 
and 62% specificity.12 Research to diagnose 
diastolic dysfunction by using P-wave dispersion 
with all subjects who were hypertension patients 
has never been done beforeusing the ASE/
EACVI 2016 recommendations. To the author 
best knowledge, this research is the first to apply 
the new guidelines to use P-wave dispersion to 
diagnose diastolic dysfunction.
Ischemic heart disease has been known to 
influence P-wave dispersion based on Dilaveris et 
al. (2001) studies in patients with stable angina.13 
Another study found no significant differences 
between the two groups.11 This result is similar 
to our study that had significant ischemic heart 
disease on P-wave dispersion in bivariate tests 
but not significant after multivariate tests. This 
result is probably due to our exclusion of patients 
with decreased fraction ejection where most of 
the causes are ischemic heart disease.
Gender and age did not show statistically 
significant differences, this result is different 
from the study of Barutcu et al.(2009) which 
stated that P-wave dispersion will increase with 
age,14 but according toa study from Dagli et al. 
(2008) there were no significant differencesof 
P-wave dispersion in terms of age and sex in 
hypertensive patients compared with normal 
patients.15 In our study systolic and diastolic 
blood pressure variables also did not differ 
significantly (p=0.946 and 0.052) respectively.
The use of CCB medication was not 
significantly correlated to P-wave dispersion. 
The subjects in our study mostly used CCB 
medication in the form of amlodipine. The results 
of this study are consistent with previous studies 
by Fogari et al. (2008) which suggest that the 
use of amlodipine does not significantly reduce 
P-wave dispersion compared with patients 
receiving both valsartan and ramipril therapy.16
Subjects in our study used ARB in the 
form of telmisartan, irbesartan, valsartan, 
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and candesartan. The use of ARB remained 
significantly correlated with P-wave dispersion 
after a multivariate analysis was performed with 
p=0.005; OR 0.25 (95% CI 0.094-0.664). The 
use of ARB also has a significant correlation 
with diastolic dysfunction with a p value of 0.02, 
OR 0.215 (95% CI 0.059-0.78). This result show 
the use of ARB to be a confounding factor in 
this study. 
The use of ARB has the effect of reducing 
the risk of diastolic dysfunction, as showed by 
Cuocolo et al. (1999) that patients whose received 
valsartan administration tend to have improved 
LV filling and better diastolic function.17 This study 
found that ACE inhibitor use was not significantly 
correlatedwith P-wave dispersion (p 0.788; OR 
1.195 95%; CI: 0.327-4.369). This difference may 
be due to the small number of subjects using 
ACE inhibitors, i.e.11 subjects (9.7%) of a total of 
113 subjects when compared to the proportion of 
subjects in the previous study.18,19 Previous studies 
with subjects of hypertensive patients and history of 
atrial fibrillation showed that valsartan and ramipril 
had a similar effect of decreasing blood pressure 
compared to amlodipine, but valsartan had a 
better reduction in P-wave dispersion compared to 
ramipril while amlodipine did not decrease P-wave 
dispersion. The mechanisms underlying the effects 
of P-wave dispersion reduction are not known for 
certain, but ARB and ACE inhibitors are considered 
to have antiarrhythmic effects through various 
pathways such as inhibiting ion channel function, 
angiotensin II induced angiotensic fibrosis, 
reducing atrial strain, improving left ventricular 
hemodynamic, and modulation of sympathetic 
nerve activation.16,20,21Our study found that beta-
blocker drugs did not affect P-wave dispersion, 
which is different from previous studies.19,22,23 This 
finding can be due to differences in the proportion 
of patients using beta blockers and the type of beta 
blockers used. The subjects of this study mostly 
used bisoprolol where the effect of bisoprolol on 
P-wave dispersion has not been studied previously. 
LIMITATIONS
Several limitations should be considered in 
interpreting our results. The proportion of subjects 
with diastolic dysfunction is small when compared 
to the total number of subjects, so the result may 
not be able to accurately describe the condition in 
the general population. Since research subjects 
continued to receive antihypertensive therapy, 
the variety of medication used and their effect 
on P-wave dispersion could not be completely 
eliminated as confounding variables.
CONCLUSION
This research is the first study to investigate 
the diagnostic value of P-wave dispersion to 
detect diastolic function using ASE/EACVI 2016 
recommendations. Our findings demonstrate that 
P-wave dispersion above cut-off point 71.4 m.s 
has moderate diagnostic value to detect diastolic 
dysfunction.
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